Mintz Levin Hosts M2D2 $100K Challenge Awards Event

Mintz Levin Hosts M2D2 5th Annual Challenge

Boston, MA – Mintz Levin is pleased to announce the winners of M2D2’s 5th Annual $100K Challenge, a start-up competition focused on identifying and rewarding disruptive companies in the medical technology and biotechnology industries. The firm hosted the awards ceremony on April 6th in its Boston office.

Winners of the competition each received in-kind support from the competition’s sponsors equaling $100,000, including in-kind legal services from Mintz Levin, a Platinum Sponsor of the event. The winners of this year’s competition were:

  • 1st Place           Innoblative – RFA applicator for breast cancer
  • 2nd Place (tie) LaunchPad Medical – Bone glue
  • 2nd Place (tie) Biorasis – Smallest, most accurate continuous glucose monitoring
  • 3rd Place (tie)   Kohana – Breast pump
  • 3rd Place (tie)   Disease Diagnostic – Low cost, portable, reusable device to detect malaria & other diseases
  • Honorable Mention    Cre8MDI – Cardiovascular risk predictor
  • Peoples Choice NonSpec – Low cost, high functionality replacement limbs

Additional companies were recognized by and will receive support from Boston Scientific (Astraeus Technologies, Vital Sines and Embryyo) and Becton Dickinson (Fluid Screen and Clinitech).

“The competition in the program has grown from good to amazing in just 5 years. The quality and preparedness of the dozens of companies in this year’s challenge was remarkable and made the job of judging them very difficult,” said William Geary, a Member of Mintz Levin’s Intellectual Property Section and a long-time member of M2D2’s Advisory Board.   “Mintz Levin is proud to support M2D2 and excited to have had the opportunity to coach most of the entrepreneurs behind the finalist companies.”

“The professionals at M2D2, including Steve McCarthy, Steve Tello, Nate Safer and MaryAnn Picard, are fantastic to work with. They are entrepreneurs in their own rights, having created M2D2 from the ground up, getting the support of the University system and the Commonwealth, as well as many local corporations. It’s a real pleasure to be working with them,” added John Condon, an attorney in the firm’s Corporate Section is also a member of the M2D2 Advisory Board

 University of Massachusetts President Marty Meehan was on hand to kick-off the awards night and recognized the intensity of effort that lead to creating M2D2 at UMass Lowell and the pride he feels in seeing the collaboration with the Worcester campus which strengthens the venture and serves as a great example for the success which can be achieved through collaborative efforts among the University of Massachusetts campuses across the Commonwealth.

President Meehan introduced State Senator Eileen Donoghue, who represents the 1st Middlesex District of Massachusetts, which includes Lowell. A former Mayor and City Councilor of Lowell, Senator Donoghue is a tremendous supporter of UMass Lowell and M2D2. She spoke with pride of the business opportunity represented by M2D2 and the companies it fosters. Senator Donoghue highlighted M2D2’s economic impact, referencing the Donoghue Institute’s Innovation Effect report produced at the end of 2015 that M2D2 has contributed $75.5 million to the economy in 2014.

“We are extremely pleased with the success of the 5th Annual $100K Challenge. More than 70 companies applied from across the US and from as far away as India. The entrepreneurs brought amazing technology to the program and the competition was intense,” said Stephen P. McCarthy, Ph.D., a founding Director of M2D2 and a tenured Professor in U Mass Lowell’s Department of Plastics Engineering. “Our sponsors, including Mintz Levin, BD, Boston Scientific, MPR, Omni, R&Q, and the Massachusetts Life Sciences Center were totally engaged and incredibly supportive. Ultimately the awards went to companies which are going to have tremendous impact on the life sciences industry.”

About the M2D2 $100K Challenge

The M2D2 $100K challenge is a start-up competition focused on identifying and rewarding disruptive companies in the medical technology and biotechnology industries. In its 5th year, the competition saw more applicants and finalists than in 2016 than in any prior year. The level of company applying to compete has increased each year and included multiple past MassChallenge winners this year and recipients of funding from the Massachusetts Life Sciences Center.

About M2D2

The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the Lowell and Worcester campuses of the University of Massachusetts. M2D2 leverages the engineering, business and clinical strengths of the UMass campuses in Lowell and Worcester to provide fee-based services in the areas of business planning, product prototype development and clinical pathway assistance.

About Mintz Levin

Mintz Levin is a firm of approximately 550 attorneys and senior professionals with offices across the country and in London, UK. We are passionate about the life sciences industry and about helping start-ups achieve success. Advising entrepreneurs on the formation and growth of new businesses is a cornerstone of our practice. We help them build networks, structure their business, develop strategic plans, protect their ideas, secure financing, and put together the requisite employment and benefits programs. We thrive when our clients thrive and we are committed to supporting the start-up community, writ large and in the cites in which we work and live – Boston, New York, San Diego, San Francisco, and Washington DC.

Contact: Gina Addis – (617) 348- 4413 – gaddis@mintz.com

###

$100K Challenge A Good Fit For Diabetes Start-Ups

M2D2 at UMASS ACCEPTING APPLICATIONS FOR THEIR 5th ANNUAL COMPETITION, THE $100K CHALLENGE

Admetsys, a start-up company developing an artificial pancreas and a prior year M2D2 winner, shares their experience and the advances and connections they were able to make as a result of the M2D2 competition.

Brian of Mass Device interviews Jeff Valk, CEO of Admetsys here: http://www.massdevice.com/an-artificial-pancreas-for-hospital-and-surgical-care-the-admetsys-story/

We invite you to apply to this funding opportunity. The extended deadline is February 7, 2016. Complete information and application is here: http://bit.ly/100KChallengeM2D2

Any questions, contact Mary Ann at maryann_picard@uml.edu or (978)934-3403M2D2 Advancing med device biotech innovations

M2D2 Announces Regulatory & Quality Solutions as Newest Platinum Sponsor

M2D2 is pleased to announce that Regulatory & Quality Solutions (R&Q), a team of regulatory and quality experts with global headquarters in Pennsylvania and local offices in Boston and Cleveland, is the newest platinum corporate sponsor.

R&Q
provides integrated quality and regulatory consulting solutions to medical
device companies ‘ including start-ups. They support the lifecycle of medical
devices from conceptual development through post-market surveillance, providing
solutions that accelerate the success of medical device companies and improve
people’s lives.

As you can see in the video clip (pic.twitter.com/QnLhSrC56B),Christine Santagate and Theresa Miles from R&Q wasted no time participating in an M2D2 event and interacting with resident companies. Christine was a contestant and Theresa was a judge in M2D2’s recent “Family Feud” business panel event sponsored by both Duane Morris LLP and MPR Product Development.
More information about R&Q can be found at www.rqteam.com. M2D2 is a joint project between UMass Lowell and the UMass Medical School. More information about M2D2 can be found at www.uml.edu/m2d2 or by sending an inquiry to M2D2@uml.edu.

M2D2 Welcomes First Resident Company to New Biotech Center

M2D2 is pleased to welcome KnipBio as the first resident company in their new biotech center located in the Freudenberg Building at 110 Canal Street in Lowell MA. KnipBio is working on a novel human health and aquaculture technology.

The 11,000 square foot center is made up of a fully-equipped, shared lab facility that can house 50 researchers and also includes plenty of co-working and meeting spaces. Add in parking and its close (3-block, 7-minute walk) proximity to the MBTA commuter rail, and you have the perfect new home for Boston start-ups!
Start-up companies and entrepreneurs utilizing M2D2’s new center will have access to all UMass Lowell and the UMass Medical School in Worcester have to offer. Engineering, prototyping, clinician review, animal trials, clinical trials, business mentoring, and partnerships with investors are all available at their fingertips.
More information and tours are available by contacting M2D2@uml.edu; telephone (978)934-3465.
IMG_0425.JPG










KnipBio’s CEO Larry Feinberg (L) and M2D2 Director Steve McCarthy (R) prepare for the move

IMG_0408.JPG











KnipBio’s lead scientist Catherine Pujol-Baxley (L) and CEO Larry Feinberg (R)

IMG_0424.JPG










KnipBio’s COO, Jessica McLear, helps with the move

IMG_0421.JPG
















The KnipBio team moving in. They are all thumbs-up about their new home!

M2D2 Countdown is On!

Best not to say “ready for blastoff” when referring to a lab facility!

So let’s just say crews are putting the finishing touches on M2D2’s brand spanking new, light and bright, fully equipped shared lab facility in Lowell MA. Within a few short weeks M2D2 will be ready to welcome many more medical device and biotech start-up entrepreneurs.
Banners.jpg
IMG_0308.JPG
IMG_0305.JPG
IMG_0314.JPG
IMG_0318.JPG
Among the features are:
  • Lab space
  • Lab equipment with maintenance & tech support
  • Lab training & EHS compliance
  • Waste removal
  • Access to UMass Medical School resources
  • Access to UMass Lowell business, engineering & prototyping resources
  • Secure access
  • Parking
  • Easy access to MBTA Commuter Rail
  • Conference rooms & meeting spaces
  • Co-working area
  • Internet
  • Kitchen cafe area
  • Educational programming for start-up companies
We can’t wait to show you this new lab facility less than 30 miles from Boston!
Rates have been set and tours are available. Be in touch by email at M2D2@uml.edu or by telephone (978)934-3465.

M2D2 Participates in NH Governor Maggie Hassan Visit

M2D2 was pleased to participate when New Hampshire Governor Maggie Hassan paid a visit to platinum corporate sponsor Omni Components recently.

Omni Components, located in Hudson NH, is a manufacturer of medical devices and other precision machined products. Governor Hassan was interested to learn firsthand of Omni’s recent improvements in workforce and career development, energy consumption, streamlined manufacturing processes, and work environment.
During her tour of the plant, Governor Hassan learned about Omni’s “green” initiative with efforts to reduce waste. She also learned about their installation of state-of-the-art air cleaning machinery for air quality and employee comfort. During the roundtable discussion that followed, Governor Hassan fielded questions from the audience and learned more about Omni’s support of M2D2 and UMass Lowell. Omni is a supporter of UMass Lowell by hiring student interns from the university’s engineering faculties. Omni is also a big supporter of M2D2 by seeking to work one-on-one with associated start-up companies in all aspects of their entrepreneurial endeavors.
Steve Mary Ann tour.jpg
Plant tour at Omni Components in Hudson NH
Governor tour2.jpg




Governor Hassan speaks with Omni employee about recent air quality improvements
Frank Gov MAP Steve M.jpg
L to R: Frank Stone, CEO of Omni Components; Governor Maggie Hassan; Mary Ann Picard, Associate Director of M2D2; Stephen McCarthy, PhD, Director of M2D2 at UMass Lowell

M2D2 Lowell High School Partnership to be Featured on Boston TV

Boston’s WBZ TV-4 will feature the M2D2 Lowell High School Partnership Program during its weekly student segment next Monday, May 11th at 5:00.

Paula Ebben of WBZ interviewed the LHS honors level students involved in the program, UMass Lowell intern Kreg Kaminski who leads the curriculum and Stephen McCarthy, PhD, Director of the Massachsetts Medical Device Development Center at UMass Lowell.
Tune in on Monday to hear more about this unique partnership which introduces high school students to the world of medical device invention and the business path to commercialization.
IMG_2577 (2).jpg
Paula Ebben of WBZ TV-4 interviewing students in the M2D2 Lowell High School Partnership Program
IMG_2578 (2).jpg


Paula Ebben of WBZ-TV4 interviewing UMass Lowell intern Kreg Kaminski
IMG_2583 (2).jpg
Paula Ebben of WBZ-TV4 interviewing Stephen McCarthy, PhD, Director of M2D2

M2D2 To Open Fully Equipped Shared Lab Space June 1st

The countdown is on! M2D2 is growing and we couldn’t be more excited! In just a few short weeks we will open an additional center with fully-equipped shared lab and collaborative space.

M2D2 will provide:
  • Lab space
  • Lab equipment with maintenance and tech support
  • Lab training & EHS compliance
  • Waste removal
  • Access to UMass Medical School resources
  • Access to UMass Lowell business, engineering, & prototyping services
  • Secure access
  • Parking
  • Easy access to MBTA Commuter Rail
  • Conference rooms
  • Event space
  • Internet
  • Kitchen
  • Educational programming tailored to life science start-up companies
Lab.jpg

Lab2.jpg

Flex rooms.jpg

Reception area.jpg

After all these months of planning and construction, we can’t wait to welcome even more early stage med device and biotech innovators!
Take a look at the photos for a quick peek then send an email or give us a call to tour: M2D2@uml.edu or 978-934-3465

M2D2 Contest Draws More Than 60 Startups

Medical Device Entrepreneurs Pitch Ideas

Ruth Cheng, director of strategy and innovation for Smith & Nephew, was one of six judges who questioned competitors at M2D2's venture contest.

Ruth Cheng, director of strategy and innovation for Smith & Nephew, was one of six judges who questioned competitors at M2D2’s venture contest.

04/03/2015

ByDavid Perry

Drawing more than 60 applicants from as far away as Israel, and a crowd that spilled into the hallways, theMassachusetts Medical Device Development Center‘s (M2D2) New Venture Competition was a sure sign of the program’s growth and ingenuity.

The competition, the fourth one held to date, is where innovations in medicine and engineering intersect and fledgling businesses try to find legs in the marketplace.

‘It used to be that we had a hard time getting people to come up from Boston,’ saidSteven Tello, an M2D2 director and the associate vice chancellor for entrepreneurship and economic development. ‘But now that’s not the case. I think people see the companies we’ve worked with have been successful and people have wondered, ‘Let’s see what is happening up there.’ And the Saab building (the Emerging Technologies and Innovation Center) caught people’s attention. When they saw that, they knew Lowell had all the pieces.’

M2D2, a UMass Lowell-UMass Worcester collaboration that helps entrepreneurs advance their ideas for medical device products, offers prototyping and product development help, regulatory and business development assistance as well as lab and office space.

In the venture competition, the pool of 64 applicants was winnowed down to 15 finalists, who then served up four-minute pitches to a panel of six judges, including John Kummailil (’96, plastics engineering), senior manager of corporate engineering for Boston Scientific. At stake is more than $100,000 in in-kind services from sponsors, including legal, business and regulatory support, lab and office space and more. Winners will be announced at the offices of Boston law firm Mintz Levin on April 16.

The pitches addressed a variety of illnesses and conditions, including automated glucose control (by Boston-based Admetsys) for a population increasingly riddled with diabetes, Syracuse-based Fusologics’ accelerated bone formation, Georgia-based LunaMed’s cancer tissue evaluation system and implant technology from the Israeli firm Resorbium.

Rithi Srinivas pitched Boston-based Novopyxis’ system for delivering antibiotics to treat skin and soft tissue infections. She felt well-prepared delivering her pitch to the judges.

‘Part of it is knowing the technology,’ she said later. ‘Knowing it well helps, but I practiced and practiced the presentation. I have given the talk four or five times before.’

For all the expertise and experience that came through in the presentations, all were small companies, with no more than five employees, most with just three.

In the hallway outside the Jacqueline and Edward J. Moloney Jr. Ballroom on the second floor of University Crossing, more than 30 applicants stood alongside posters of their projects. Everything from neuro-modulation for chronic back pain to an intracranial assessment was in play. Guests, each given $1 million in fake money upon entering, doled it out to those with the most deserving pitches. (One will emerge as the People’s Choice winner on April 16).

Laura Indolfi and David Ting of Panther Therapeutics pitched what they described as ‘technologies for revolutionizing the treatment of pancreatic cancer.’

‘The project started two-and-a-half years ago,’ said Indolfi. ‘The past two years have been focused on science and only in the last few months have we been doing pitches parallel with science. It is about getting funding assistance to get to the next steps.’

Ting, a clinician, who runs a lab at MIT, said that no matter how profound the science, it needs to marry with business to go from theory to market.

‘If you have a problem, you could do a lot worse than working with a bunch of MIT engineers to help solve it. But in terms of starting a company, I don’t know how to do that. But I know there are people out there who can.’

And the Moloney Ballroom was where to find them on April 1.